Phase 3 clinical trial of a novel oral benzimidazole riboside in transplant recipients with cytomegalovirus (CMV) infections that are refractory to available antiviral treatment

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
Phase 3 clinical trial of a novel oral benzimidazole riboside in transplant recipients with cytomegalovirus (CMV) infections that are refractory to available antiviral treatment

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.